| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyoderma Gangrenosum | 5 | 2018 | 86 | 0.690 |
Why?
|
| Murinae | 1 | 2015 | 18 | 0.520 |
Why?
|
| Sunlight | 2 | 2011 | 337 | 0.380 |
Why?
|
| Skin | 4 | 2020 | 4520 | 0.360 |
Why?
|
| Dapsone | 2 | 2018 | 56 | 0.310 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 1100 | 0.300 |
Why?
|
| Vitamin D | 2 | 2011 | 3311 | 0.270 |
Why?
|
| Regeneration | 1 | 2015 | 1527 | 0.270 |
Why?
|
| Eye Diseases | 3 | 1995 | 657 | 0.200 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 1389 | 0.190 |
Why?
|
| Leg Ulcer | 1 | 2021 | 71 | 0.180 |
Why?
|
| Dermatitis, Irritant | 1 | 2020 | 18 | 0.180 |
Why?
|
| Dermatitis, Occupational | 1 | 2020 | 26 | 0.180 |
Why?
|
| Hydroxyurea | 1 | 2021 | 284 | 0.170 |
Why?
|
| Ulcer | 1 | 2021 | 204 | 0.170 |
Why?
|
| Nylons | 1 | 1999 | 46 | 0.170 |
Why?
|
| Sclera | 2 | 1999 | 190 | 0.160 |
Why?
|
| Bandages | 1 | 2020 | 273 | 0.150 |
Why?
|
| Scalp Dermatoses | 1 | 2018 | 44 | 0.150 |
Why?
|
| Roseolovirus Infections | 1 | 2018 | 50 | 0.150 |
Why?
|
| Herpesvirus 6, Human | 1 | 2018 | 98 | 0.150 |
Why?
|
| Corneal Ulcer | 1 | 1999 | 127 | 0.150 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2018 | 85 | 0.140 |
Why?
|
| Sutures | 1 | 1999 | 283 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2010 | 3445 | 0.140 |
Why?
|
| Eye Injuries | 1 | 2000 | 228 | 0.140 |
Why?
|
| Clinical Coding | 1 | 2018 | 186 | 0.130 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 1999 | 354 | 0.130 |
Why?
|
| Neurosyphilis | 1 | 1995 | 27 | 0.130 |
Why?
|
| Cysticercosis | 1 | 1995 | 34 | 0.130 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 1995 | 39 | 0.130 |
Why?
|
| Conjunctiva | 1 | 1999 | 478 | 0.130 |
Why?
|
| Scalp | 1 | 2018 | 392 | 0.120 |
Why?
|
| Paraproteinemias | 1 | 2018 | 254 | 0.120 |
Why?
|
| Uveitis | 1 | 1999 | 398 | 0.120 |
Why?
|
| Dermatologic Agents | 1 | 2018 | 314 | 0.120 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1995 | 155 | 0.110 |
Why?
|
| Hypopigmentation | 1 | 2013 | 43 | 0.110 |
Why?
|
| Thiosulfates | 1 | 2013 | 53 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2010 | 1943 | 0.110 |
Why?
|
| Temporal Arteries | 1 | 1994 | 155 | 0.100 |
Why?
|
| Arthritis | 1 | 2018 | 685 | 0.100 |
Why?
|
| Laser Therapy | 1 | 1999 | 1107 | 0.100 |
Why?
|
| Vision Disorders | 1 | 1999 | 1092 | 0.100 |
Why?
|
| Nerve Degeneration | 2 | 2009 | 750 | 0.100 |
Why?
|
| Pemphigoid, Bullous | 1 | 2013 | 113 | 0.100 |
Why?
|
| Retinal Hemorrhage | 1 | 1992 | 98 | 0.100 |
Why?
|
| Chelating Agents | 1 | 2013 | 385 | 0.100 |
Why?
|
| Calciphylaxis | 1 | 2013 | 130 | 0.090 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2013 | 235 | 0.090 |
Why?
|
| Species Specificity | 1 | 2015 | 2422 | 0.090 |
Why?
|
| Down Syndrome | 1 | 1999 | 914 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 987 | 0.090 |
Why?
|
| Skull Fractures | 1 | 1992 | 203 | 0.090 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 400 | 0.080 |
Why?
|
| Giant Cell Arteritis | 1 | 1994 | 307 | 0.080 |
Why?
|
| Adipocytes, White | 1 | 2010 | 92 | 0.080 |
Why?
|
| Visual Acuity | 1 | 1999 | 2714 | 0.080 |
Why?
|
| Athletic Injuries | 1 | 2000 | 1242 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 1891 | 0.080 |
Why?
|
| Ferrets | 1 | 2009 | 181 | 0.080 |
Why?
|
| Prednisone | 1 | 1994 | 1568 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2126 | 0.080 |
Why?
|
| Florida | 1 | 2010 | 430 | 0.080 |
Why?
|
| Polycythemia Vera | 2 | 2021 | 161 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 4083 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2018 | 4041 | 0.070 |
Why?
|
| Wound Healing | 1 | 2018 | 2819 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2008 | 313 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2018 | 3472 | 0.070 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 402 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 1999 | 2260 | 0.070 |
Why?
|
| Brain Diseases | 1 | 1995 | 1553 | 0.070 |
Why?
|
| Administration, Topical | 2 | 2018 | 707 | 0.070 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2013 | 1092 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2013 | 1205 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2018 | 2444 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1937 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2009 | 4948 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2013 | 1099 | 0.060 |
Why?
|
| Intra-Abdominal Fat | 1 | 2010 | 623 | 0.060 |
Why?
|
| Leukemia | 1 | 1992 | 1527 | 0.060 |
Why?
|
| Biopsy | 4 | 2018 | 6816 | 0.060 |
Why?
|
| Seasons | 1 | 2010 | 1526 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5891 | 0.050 |
Why?
|
| Retinal Ganglion Cells | 1 | 2009 | 811 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 2465 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2009 | 1503 | 0.050 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2002 | 77 | 0.050 |
Why?
|
| Humans | 31 | 2023 | 768451 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2018 | 8081 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2011 | 1307 | 0.050 |
Why?
|
| Photoreceptor Cells | 1 | 2002 | 235 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 1992 | 2665 | 0.050 |
Why?
|
| Scrotum | 1 | 2021 | 117 | 0.040 |
Why?
|
| Male | 20 | 2021 | 364781 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4877 | 0.040 |
Why?
|
| Eye Protective Devices | 1 | 2000 | 33 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2002 | 458 | 0.040 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2000 | 201 | 0.040 |
Why?
|
| Anisometropia | 1 | 1999 | 17 | 0.040 |
Why?
|
| Female | 20 | 2020 | 396943 | 0.040 |
Why?
|
| Collagen Diseases | 1 | 1999 | 39 | 0.040 |
Why?
|
| Chills | 1 | 2018 | 17 | 0.040 |
Why?
|
| Retinitis Pigmentosa | 1 | 2002 | 397 | 0.040 |
Why?
|
| Retina | 1 | 2009 | 2663 | 0.040 |
Why?
|
| Prevalence | 2 | 2018 | 15880 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2023 | 1656 | 0.040 |
Why?
|
| Refractive Errors | 1 | 1999 | 148 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2000 | 471 | 0.040 |
Why?
|
| Amblyopia | 1 | 1999 | 152 | 0.040 |
Why?
|
| Lung Diseases | 1 | 1987 | 1926 | 0.030 |
Why?
|
| Sjogren's Syndrome | 1 | 1999 | 242 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2011 | 2291 | 0.030 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2018 | 160 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2000 | 1053 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 863 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2002 | 960 | 0.030 |
Why?
|
| Neoplasms | 2 | 2018 | 22386 | 0.030 |
Why?
|
| Rifabutin | 1 | 1995 | 59 | 0.030 |
Why?
|
| Debridement | 1 | 2018 | 494 | 0.030 |
Why?
|
| Thyroid Diseases | 1 | 1999 | 388 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 5709 | 0.030 |
Why?
|
| Strabismus | 1 | 1999 | 317 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15880 | 0.030 |
Why?
|
| Myeloproliferative Disorders | 1 | 2021 | 614 | 0.030 |
Why?
|
| Mohs Surgery | 1 | 2017 | 222 | 0.030 |
Why?
|
| Animals | 9 | 2015 | 169418 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 1615 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2018 | 81834 | 0.030 |
Why?
|
| Face | 1 | 2020 | 1031 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 1995 | 560 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2008 | 2891 | 0.030 |
Why?
|
| Thoracic Nerves | 1 | 1973 | 21 | 0.030 |
Why?
|
| Exanthema | 1 | 2018 | 504 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 13026 | 0.030 |
Why?
|
| Middle Aged | 9 | 2018 | 223418 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 1337 | 0.030 |
Why?
|
| Hair Color | 1 | 2013 | 131 | 0.030 |
Why?
|
| Rabbits | 1 | 1999 | 4786 | 0.030 |
Why?
|
| Leukemic Infiltration | 1 | 1992 | 47 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 59680 | 0.030 |
Why?
|
| Vitiligo | 1 | 2013 | 100 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2884 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2013 | 281 | 0.030 |
Why?
|
| Prognosis | 3 | 2000 | 30028 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 925 | 0.030 |
Why?
|
| Erythema | 1 | 2013 | 262 | 0.020 |
Why?
|
| Adult | 9 | 2020 | 223542 | 0.020 |
Why?
|
| Diagnostic Errors | 2 | 2018 | 1282 | 0.020 |
Why?
|
| Contusions | 1 | 1992 | 79 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2013 | 278 | 0.020 |
Why?
|
| Diaphragm | 1 | 1973 | 360 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2010 | 23638 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2238 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2010 | 3594 | 0.020 |
Why?
|
| Fever | 1 | 2018 | 1622 | 0.020 |
Why?
|
| Aged | 7 | 2018 | 171520 | 0.020 |
Why?
|
| Melanocytes | 1 | 2013 | 512 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2010 | 208 | 0.020 |
Why?
|
| Adolescent | 5 | 2013 | 89168 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2020 | 8730 | 0.020 |
Why?
|
| Eye | 1 | 1992 | 715 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2279 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7471 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 474 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2010 | 19041 | 0.020 |
Why?
|
| Obesity | 1 | 2010 | 13065 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 626 | 0.020 |
Why?
|
| Remission Induction | 1 | 2013 | 2408 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 384 | 0.020 |
Why?
|
| Dendrites | 1 | 2009 | 471 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 1992 | 821 | 0.020 |
Why?
|
| Respiration | 1 | 1973 | 1667 | 0.020 |
Why?
|
| Health Personnel | 1 | 2020 | 3384 | 0.020 |
Why?
|
| Conjunctival Diseases | 1 | 1987 | 109 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 21156 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2018 | 65409 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1992 | 813 | 0.020 |
Why?
|
| Mutation | 2 | 2008 | 30243 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1992 | 1348 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9687 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1973 | 1814 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2018 | 5995 | 0.020 |
Why?
|
| Vitreous Body | 1 | 1987 | 400 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 8908 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8510 | 0.010 |
Why?
|
| Breast | 1 | 2013 | 1976 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9361 | 0.010 |
Why?
|
| Accidental Falls | 1 | 1992 | 1081 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1992 | 1557 | 0.010 |
Why?
|
| Child Abuse | 1 | 1992 | 1092 | 0.010 |
Why?
|
| Comorbidity | 1 | 2018 | 10601 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2010 | 2944 | 0.010 |
Why?
|
| Binding Sites | 2 | 2002 | 6030 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 1669 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 3763 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2942 | 0.010 |
Why?
|
| Acute Disease | 1 | 1992 | 7246 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15460 | 0.010 |
Why?
|
| Risk Factors | 2 | 2017 | 74915 | 0.010 |
Why?
|
| Incidence | 1 | 2000 | 21552 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39430 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2002 | 224 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18478 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 20231 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2013 | 3042 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1987 | 711 | 0.010 |
Why?
|
| Brain Concussion | 1 | 1992 | 1430 | 0.010 |
Why?
|
| United States | 2 | 2018 | 73121 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15965 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13655 | 0.010 |
Why?
|
| Infant | 2 | 1992 | 36497 | 0.010 |
Why?
|
| Pedigree | 1 | 2008 | 4545 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11138 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2002 | 617 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2000 | 362 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1992 | 42623 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4120 | 0.010 |
Why?
|
| Motor Activity | 1 | 2009 | 2722 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2002 | 699 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 1144 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 4180 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2002 | 969 | 0.010 |
Why?
|
| Child | 3 | 1999 | 80863 | 0.010 |
Why?
|
| Fibroma | 1 | 1980 | 201 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20762 | 0.010 |
Why?
|
| Orbital Neoplasms | 1 | 1980 | 223 | 0.010 |
Why?
|
| Survival Rate | 1 | 1992 | 12875 | 0.010 |
Why?
|
| CHO Cells | 1 | 2000 | 1382 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 1563 | 0.010 |
Why?
|
| Dogs | 1 | 2002 | 3847 | 0.010 |
Why?
|
| Cricetinae | 1 | 2000 | 2423 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2000 | 572 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1775 | 0.010 |
Why?
|
| Mice | 3 | 2010 | 82045 | 0.010 |
Why?
|
| Protein Transport | 1 | 2002 | 1963 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 2751 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2184 | 0.010 |
Why?
|
| Suppuration | 1 | 1995 | 61 | 0.010 |
Why?
|
| Ophthalmology | 1 | 1982 | 560 | 0.010 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 1995 | 76 | 0.010 |
Why?
|
| Uveitis, Anterior | 1 | 1995 | 101 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 3530 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 14480 | 0.010 |
Why?
|
| Vagotomy | 1 | 1973 | 83 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2002 | 2450 | 0.010 |
Why?
|
| Spinal Nerves | 1 | 1973 | 92 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 6348 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 1982 | 1299 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 3664 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 5767 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1992 | 26395 | 0.010 |
Why?
|
| Cats | 1 | 1973 | 978 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2882 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 3735 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1995 | 664 | 0.010 |
Why?
|
| Mechanoreceptors | 1 | 1973 | 194 | 0.010 |
Why?
|
| Apnea | 1 | 1973 | 195 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 2910 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 1973 | 498 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 22365 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 6527 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 10784 | 0.010 |
Why?
|
| Pressure | 1 | 1973 | 1173 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18388 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4534 | 0.010 |
Why?
|
| Feedback | 1 | 1973 | 794 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13452 | 0.000 |
Why?
|
| Brain | 1 | 1995 | 27438 | 0.000 |
Why?
|
| Cell Line | 1 | 2002 | 15609 | 0.000 |
Why?
|
| Electromyography | 1 | 1973 | 1399 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1995 | 36840 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 2000 | 5152 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 17647 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1992 | 54914 | 0.000 |
Why?
|
| Rats | 1 | 2002 | 23839 | 0.000 |
Why?
|
| Action Potentials | 1 | 1973 | 1837 | 0.000 |
Why?
|
| Ophthalmoscopy | 1 | 1982 | 172 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1995 | 12450 | 0.000 |
Why?
|
| Exophthalmos | 1 | 1980 | 100 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1982 | 3629 | 0.000 |
Why?
|
| Primary Health Care | 1 | 1982 | 4737 | 0.000 |
Why?
|